BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,061 filers reported holding BAXTER INTL INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $106 | -28.9% | 2,836 | -13.5% | 0.00% | -33.3% |
Q2 2023 | $149 | +140.3% | 3,278 | +113.4% | 0.00% | +200.0% |
Q1 2023 | $62 | +8.8% | 1,536 | +35.7% | 0.00% | 0.0% |
Q4 2022 | $57 | -99.9% | 1,132 | +17.9% | 0.00% | -66.7% |
Q3 2020 | $77,000 | -9.4% | 960 | -2.8% | 0.00% | -25.0% |
Q2 2020 | $85,000 | -15.8% | 988 | -14.5% | 0.00% | -42.9% |
Q1 2020 | $101,000 | -2.9% | 1,155 | -0.6% | 0.01% | 0.0% |
Q4 2019 | $104,000 | +36.8% | 1,162 | +32.0% | 0.01% | +16.7% |
Q3 2019 | $76,000 | +55.1% | 880 | +46.2% | 0.01% | +50.0% |
Q2 2019 | $49,000 | -84.9% | 602 | -85.0% | 0.00% | -84.6% |
Q1 2019 | $325,000 | -79.1% | 4,013 | -80.1% | 0.03% | -72.9% |
Q3 2018 | $1,556,000 | – | 20,190 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |